Effect of chaethomellic acid on renal function in a rat model of chronic renal failure by Nogueira, António José M. et al.
EFFECT OF CHAETHOMELLIC ACID ON RENAL 
FUNCTION IN A RAT MODEL OF CHRONIC RENAL 
FAILURE
Nogueira AJ1, Fonte ME1, Oliveira PA1, Colaço B2, López-Novoa JM3, Mega C4, Colaço A1, Pires MJ1
1Department of Veterinary Science, Center for the Study of Animal Sciences, ECAV, University of Trás-os-Montes and Alto Douro, Vila Real, Portugal
2Department of Zootecnia, Center for the Study of Animal Sciences, ECAV, University of Trás-os-Montes and Alto Douro, Vila Real, Portugal
3Renal and Cardiovascular Physiopathology Unit, Reina Sofía Institute for Renal Research, Department of Physiology and Pharmacology, University of Salamanca, 
Biomedical Research Institute of Salamanca, Salamanca, Spain
4Department of Animal Science, Rural Engineering and Veterinary Science, Agrarian Superior School of Polytechnic Institute of Viseu, Viseu, Portugal
RESULTS
Renal function parameters are shown in table 1. BUN (figure 1), creatinine (figure 2) and urinary protein excretion (figure 3)
were significantly lower and creatinine clearance (figure 4) was significantly higher in the SO and SO+AC groups when
compared with the RMR and RMR+AC groups. There were no significantly differences in creatinine, urinary protein
excretion and creatinine clearance between the RMR and RMR+AC groups. However, the RMR+AC group showed
significantly lower BUN and lower creatinine and urinary protein excretion, and higher creatinine clearance than the RMR
group.
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MATERIALS AND METHODS
Animal care and treatment were conducted in conformity with institutional guidelines that are in compliance with
international laws and politics. Male Wistar rats were subjected to 5/6 nephrectomy (RMR) or sham-operated (SO). One
week after surgery, rats have been randomized and placed in four experimental groups: RMR: RMR rats without treatment
(n=13); RMR+AC: RMR rats treated with AC (n=13); SO: SO rats without treatment (n=13); SO+AC: SO rats treated with AC
(n=13). AC was intraperitoneally administered in a dose of 0.23 µg/Kg three times a week for six months. Creatinine, blood
urea nitrogen (BUN), electrolytes and protein were measured in serum and/or urine by routine laboratory techniques. The
differences between groups were evaluated by one-way analysis of variance (ANOVA) followed by Bonferroni post hoc
tests. All data are presented as the mean ± SD and were considered significant at p<0.05.
INTRODUCTION
Chaethomellic acid (AC) is a highly specific inhibitor of ras farnesyl-protein transferase. The aim of this study has been to
evaluate the effect of chronic treatment with chaethomellic acid (CA) on the renal function of rats with renal failure induced
by renal mass reduction.
CONCLUSIONS
These results suggest that in a model of renal failure induced by RMR, six months of treatment with chaethomellic acid
may have some beneficial effect on renal function.
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Table 1: Effect of chaethomellic acid on renal function parameters after renal mass reduction.
Parameters SO(n = 13)
SO+AC
(n = 13)
RMR
(n = 12)
RMR+AC
(n = 8) ANOVA POST HOC 
(1)
Urinary Flow (µl/min.)
Md = 0,010
M = 0,011
SD = 0,002
Md = 0,009
M = 0,009
SD = 0,003
Md = 0,027
M = 0,029
SD = 0,008
Md = 0,023
M = 0,025
SD = 0,009
F(3,42) = 34,729
p < .001
SO vs. RMR**
SO vs. RMR+AC**
SO+AC vs. RMR**
SO+AC vs. RMR+AC**
Sodium (mmol/l)
Md = 144,600
M = 145,170
SD = 1,831
Md = 143,960
M = 142,299
SD = 6,784
Md = 145,735
M = 146,957
SD = 4,218
Md = 147,245
M = 146,388
SD = 3,569
F(3,42) = 2,497
p = .073
Potassium (mmol/l)
Md = 4,810
M = 4,808
SD = 0,355
Md = 4,710
M = 4,511
SD = 0,662
Md = 5,230
M = 5,275
SD = 0,472
Md = 4,820
M = 4,849
SD = 0,408
F(3,42) = 4,964
p = .005 SO+AC vs. RMR**
Chloride (mmol/l)
Md = 101,190
M = 102,522
SD = 4,268
Md = 101,340
M = 99,715
SD = 7,811
Md = 104,535
M = 105,264
SD = 5,276
Md = 108,670
M = 107,284
SD = 6,241
F(3,42) = 3,186
p = .033 SO+AC vs. RMR+AC*
Calcium (mg/dl)
Md = 10,530
M = 10,533
SD = 0,366
Md = 10,830
M = 10,476
SD = 0,882
Md = 11,460
M = 11,397
SD = 0,475
Md = 11,435
M = 11,333
SD = 0,602
F(3,42) = 7,477
p < .001
SO vs. RMR**
SO vs. RMR+AC*
SO+AC vs. RMR**
SO+AC vs. RMR+AC*
Phosphorus (mg/dl)
Md = 6,420
M = 6,392
SD = 1,010
Md = 6,210
M = 6,073
SD = 0,998
Md = 7,670
M = 8,209
SD = 1,707
Md = 7,165
M = 7,481
SD = 1,363
F(3,42) = 7,140
p = .001
SO vs. RMR**
SO+AC vs. RMR**
BUN (mg/dl)
Md = 39,800
M = 40,433
SD = 6,866
Md = 45,200
M = 45,654
SD = 7,138
Md = 118,750
M = 147,167
SD = 69,824
Md = 87,125
M = 95,894
SD = 40,221
F(3,42) = 19,440
p < .001
SO vs. RMR**
SO vs. RMR+AC*
SO+AC vs. RMR**
SO+AC vs. RMR+AC**
RMR vs. RMR+AC*
Creatinine (mg/dl)
Md = 0,730
M = 0,739
SD = 0,069
Md = 0,700
M = 0,755
SD = 0,170
Md = 1,430
M = 1,691
SD = 0,799
Md = 1,085
M = 1,274
SD = 0,519
F(3,42) = 11,532
p < .001
SO vs. RMR**
SO+AC vs. RMR**
Urinary Protein 
Excretion (g/day)
Md = 1,606
M = 1,517
SD = 0,310
Md = 1,729
M = 1,667
SD = 0,412
Md = 51,494
M = 45,603
SD = 20,440
Md = 22,598
M = 35,524
SD = 30,890
F(3,42) = 23,034
p < .001
SO vs. RMR**
SO vs. RMR+AC**
SO+AC vs. RMR**
SO+AC vs. RMR+AC**
Creatinine Clearance 
(ml/min.)
Md = 1,600
M = 1,585
SD = 0,238
Md = 1,400
M = 1,462
SD = 0,301
Md = 0,700
M = 0,733
SD = 0,355
Md = 0,900
M = 0,950 
SD = 0,366
F(3,42) = 20,214
p < .001
SO vs. RMR**
SO vs. RMR+AC**
SO+AC vs. RMR**
SO+AC vs. RMR+AC**
SO: sham-operated untreated animals; SO+AC: sham-operated animals treated with chaethomellic acid; RMR: renal mass reduction untreated animals; RMR+AC: renal mass reduction
animals treated with chaethomellic acid; Md: Median; M: Mean; SD: Standard Deviation; F: statistic from ANOVA; p: significant value from ANOVA test; (1): Bonferroni post hoc test; pairs
of groups with statistically significant differences: *p < .05 and **p < .01.
Figure 1: Effect of chaethomellic acid on BUN (mg/dl) after renal mass reduction. SO: sham-operated
untreated animals; SO+AC: sham-operated animals treated with chaethomellic acid; RMR: renal mass
reduction untreated animals; RMR+AC: renal mass reduction animals treated with chaethomellic acid.
Figure 3: Effect of chaethomellic acid on urinary protein excretion (g/day) after renal mass
reduction. SO: sham-operated untreated animals; SO+AC: sham-operated animals treated with
chaethomellic acid; RMR: renal mass reduction untreated animals; RMR+AC: renal mass reduction
animals treated with chaethomellic acid.
Figure 2: Effect of chaethomellic acid on creatinine(mg/dl) after renal mass reduction. SO: sham-operated
untreated animals; SO+AC: sham-operated animals treated with chaethomellic acid; RMR: renal mass
reduction untreated animals; RMR+AC: renal mass reduction animals treated with chaethomellic acid.
Figure 4: Effect of chaethomellic acid on creatinine clearance (ml/min.)) after renal mass reduction. SO:
sham-operated untreated animals; SO+AC: sham-operated animals treated with chaethomellic acid;
RMR: renal mass reduction untreated animals; RMR+AC: renal mass reduction animals treated with
chaethomellic acid.
